Evelo Biosciences, Inc. (EVLO)

Trade EVLO now with
4/15/2020 7:04:23 AM Evelo Biosciences Appoints Neil Graham As Chief Development Officer
12/5/2019 7:15:02 AM Evelo Biosciences Appoints Juan Andres To Its Board
9/17/2019 7:09:16 AM Evelo Biosciences Appoints David Epstein As Chairman Of Board
9/17/2019 7:02:53 AM Evelo Biosciences Names David Epstein Chairman Of Its Board
1/28/2019 6:13:37 AM Evelo Says Dosing Of First Patient In Phase 2a Clinical Trial Of EDP1503 With KEYTRUDA With Metastatic Melanoma
1/8/2019 8:07:13 AM Cygnal Therapeutics Appoints Pearl Huang As CEO
1/4/2019 6:02:13 AM Evelo Biosciences Announces Dosing Of First Patient In Phase 1/2 Clinical Trial Of EDP1503 With KEYTRUDA
11/27/2018 8:09:28 AM Evelo Biosciences Enters Into Clinical Trial Collaboration Agreement With Merck
11/26/2018 8:08:01 AM Evelo Biosciences Unveils First Dosing In Phase 1b Trial Of EDP1815 In Psoriasis
11/1/2018 8:15:20 AM Evelo Biosciences Q3 Loss Per Share $0.50 Vs Loss $2.61 Last Year
8/2/2018 8:17:49 AM Evelo Biosciences Q2 Loss Attributable To Stockholders $16.7 Mln Or $0.85/Shr S Loss $7.8 Mln Or $2.09/Shr Last Year